These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32149)

  • 1. Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor.
    Pöldinger W
    Int Pharmacopsychiatry; 1978; 13(4):230-3. PubMed ID: 32149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapyramidal side effects with lithium treatment.
    Kane J; Rifkin A; Quitkin F; Klein DF
    Am J Psychiatry; 1978 Jul; 135(7):851-3. PubMed ID: 665801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
    Chaudhry R; Radonjic D; Waters B
    Am J Psychiatry; 1982 May; 139(5):674-6. PubMed ID: 6122382
    [No Abstract]   [Full Text] [Related]  

  • 4. Amantadine in the management of extrapyramidal side effects.
    Borison RL
    Clin Neuropharmacol; 1983; 6 Suppl 1():S57-63. PubMed ID: 6139167
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
    Ringwald E
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):294-8. PubMed ID: 33397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased extrapyramidal symptoms with addition of lithium to neuroleptics.
    Addonizio G; Roth SD; Stokes PE; Stoll PM
    J Nerv Ment Dis; 1988 Nov; 176(11):682-5. PubMed ID: 2903220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating extrapyramidal reactions: some current issues.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms.
    Wilbur R; Kulik FA
    Prog Neuropsychopharmacol; 1980; 4(6):627-32. PubMed ID: 6111820
    [No Abstract]   [Full Text] [Related]  

  • 11. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P; Bathien N
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract]   [Full Text] [Related]  

  • 13. Extrapyramidal syndromes in neuroleptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia.
    Muscettola G; Barbato G; Pampallona S; Casiello M; Bollini P
    J Clin Psychopharmacol; 1999 Jun; 19(3):203-8. PubMed ID: 10350026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacologic treatment of neuroleptic-induced akathisia.
    Fleischhacker WW; Roth SD; Kane JM
    J Clin Psychopharmacol; 1990 Feb; 10(1):12-21. PubMed ID: 1968470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
    Schwartz M; Weller B; Erdreich M; Sharf B
    J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of clozapine on neuroleptigenic extrapyramidal motor disturbances (author's transl)].
    Zander KJ; Rüther E
    Arzneimittelforschung; 1978; 28(9):1495-6. PubMed ID: 38808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report of propranolol (Inderal) pharmacotherapy for neuroleptic-induced akathisia and tremor.
    Kulik AV; Wilbur R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):223-5. PubMed ID: 6137028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of neuroleptic-induced extrapyramidal side effects by Kava special extract WS 1490.
    Boerner RJ; Klement S
    Wien Med Wochenschr; 2004 Nov; 154(21-22):508-10. PubMed ID: 15638068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium and extrapyramidal side effects.
    El-Defrawi MH
    Am J Psychiatry; 1982 Aug; 139(8):1079. PubMed ID: 6124137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.